167 filings
8-K
VYNT
Vyant Bio, Inc.
10 May 23
Departure of Directors or Certain Officers
8:30am
8-K
VYNT
Vyant Bio, Inc.
24 Apr 23
Vyant Bio Announces Voluntary Nasdaq Delisting and SEC Deregistration
4:50pm
8-K
VYNT
Vyant Bio, Inc.
24 Mar 23
Termination of a Material Definitive Agreement
9:12am
8-K
VYNT
Vyant Bio, Inc.
22 Mar 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
9:00am
8-K
VYNT
Vyant Bio, Inc.
15 Mar 23
Entry into a Material Definitive Agreement
6:05am
8-K
0txs l4dcf
13 Mar 23
Other Events
8:00am
8-K
27rrecpo
3 Feb 23
Cost Associated with Exit or Disposal Activities
6:02am
8-K
9nlj2rk5y83s07u8wqe
5 Jan 23
Entry into a Material Definitive Agreement
9:26am
8-K
9tf9a euysys
4 Jan 23
Vyant Bio Engages LifeSci Capital to Explore Strategic Alternatives
4:13pm
8-K
am2o0d28zjz6u099
19 Dec 22
Amendments to Articles of Incorporation or Bylaws
5:29pm
8-K
zmtmikj7 9h
5 Dec 22
Departure of Directors or Certain Officers
5:13pm
8-K
grhg3jc3qn jgf
16 Nov 22
Vyant Bio Presents Key Takeaways from Platform and Poster Presentations at Neuroscience 2022 Hosted by the Society for Neuroscience
5:26pm
8-K
phd pybivk2n
16 Nov 22
Other Events
4:59pm
8-K
f2otgcvb7n tg5ylzvvu
3 Nov 22
Reaction Biology and Vyant Bio Announce Closing of Definitive Agreement to Acquire U.S. Operations of Vyant Bio, Inc. Subsidiary
9:10am
8-K
j1k0m6f
2 Nov 22
Material Modifications to Rights of Security Holders
8:00am
8-K
ma9zaj6dt7wou07
18 Jul 22
Submission of Matters to a Vote of Security Holders
4:15pm
8-K
kmx7magbm2pddquk9
10 Jun 22
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
6:51pm
8-K
v5a1uimbepqvptd
25 May 22
Shareholder Nominations Pursuant to Exchange Act Rule 14a-11
5:59pm
8-K
i4sn1sx2niid z3lyf2
20 May 22
Unaudited Pro Forma Condensed Combined Financial Statements
4:30pm
8-K
kxp4t sxkp780p
16 May 22
Other Events
4:36pm